首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   757322篇
  免费   84815篇
  国内免费   511篇
  842648篇
  2016年   8262篇
  2015年   11389篇
  2014年   13396篇
  2013年   18897篇
  2012年   21138篇
  2011年   21674篇
  2010年   14761篇
  2009年   13782篇
  2008年   19605篇
  2007年   20594篇
  2006年   19490篇
  2005年   18581篇
  2004年   18618篇
  2003年   17585篇
  2002年   17467篇
  2001年   32239篇
  2000年   32675篇
  1999年   26101篇
  1998年   9168篇
  1997年   9562篇
  1996年   8885篇
  1995年   8474篇
  1994年   8258篇
  1993年   8313篇
  1992年   21599篇
  1991年   21185篇
  1990年   20696篇
  1989年   20079篇
  1988年   19066篇
  1987年   18173篇
  1986年   17149篇
  1985年   17201篇
  1984年   14281篇
  1983年   12320篇
  1982年   9651篇
  1981年   8819篇
  1980年   8297篇
  1979年   13844篇
  1978年   11114篇
  1977年   10231篇
  1976年   9711篇
  1975年   10711篇
  1974年   12008篇
  1973年   11755篇
  1972年   10951篇
  1971年   9873篇
  1970年   8728篇
  1969年   8567篇
  1968年   8032篇
  1967年   6846篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
291.
292.
293.
294.
295.
296.
297.
Content of dopamine in the striatum; of serotonin, 5-hydroxyindolacetic acid and noradrenaline in the hypothalamus, striatum and midbrain was studied in three groups of minks from population of an animal farm, differing by their reaction to humans (cowardly, calm, aggressive). The reaction to humans was estimated by a system of marks at the attempt to catch the mink with a mitten. Aggressive animals had a lowered level of serotonin in the hypothalamus and striatum, a lesser content of serotonin metabolite--5-hydroxyindolacetic acid in the striatum. Minks of different groups did not differ by noradrenaline content, but dopamine level in the striatum of cowardly minks was higher than in calm and aggressive animals. Conclusion is made that polymorphism of behaviour corresponds to polymorphism of the state of monoaminergic systems.  相似文献   
298.
An investigational drug (2-picoline, 6-amino-4-nitro-, 1-oxide) was evaluated to characterize the anti-coccidial spectrum of the compound. Two concentrations of the drug (125 and 250 ppm) were evaluated for bioactivity; weight gain, survival, dropping, and lesion scores were the response variables utilized to ascertain activity. The activities of the picoline derivative were compared with monensin, maduramicin, and a narasin/nicarbazin (1:1) combination. The investigational drug had significant activity against Eimeria tenella and Eimeria necatrix, and the 250-ppm level was significantly more active than 125 ppm. At 250 ppm, the E. tenella activity of the picoline derivative was comparable to both monensin (120 ppm) and the 50-ppm narasin/nicarbazin combination, significantly less effective than maduramicin (6 ppm), and significantly more efficacious than 30 ppm narasin/nicarbazin. At the same level (250 ppm), the picoline derivative had significantly less E. necatrix activity than monensin (120 ppm), maduramicin (6 ppm), and narasin/nicarbazin (50 ppm), and significantly greater activity than 30 ppm narasin/nicarbazin. At best, only extremely weak Eimeria acervulina, Eimeria brunetti, and Eimeria maxima activities were noted with the investigational drug; higher concentrations of the picoline derivative may achieve greater anti-coccidial activity against these species. The efficacy of narasin/nicarbazin compared favorably with monensin and maduramicin; the 50-ppm level of the combination appeared significantly more efficacious than 30-ppm.  相似文献   
299.
The primary structure of hemagglutinin (HA) gene of Influenza virus A/USSR/90/77 (H1N1) variants after 3 and 11 passages has been determined. In the HA1 coding region of mice-adapted virus (11 passages) there are two amino acid substitutions: Thr 89----Ala and Asn 127----Asp. At the first stage of adaptation (3-rd passage) only a single mutation was detected: Asn 127----Asp. The adaptation is accompanied by the loss of specific carbohydrate attachment sites adjacent to the receptor-binding site located at HA1 subunit with a concomitant variation in antigenicity.  相似文献   
300.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号